|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Other operating income/(expense) | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Selling, general and administrative expenses – Transformation costs | |||||
| Once off items | |||||
| Impairment charges | |||||
| Operating loss | |||||
| Financial income | |||||
| Financial expenses | |||||
| Net financing expense | |||||
| Loss before tax | |||||
| Total income tax (expense)/credit | |||||
| Loss for the year on continuing operations | |||||
| (Loss)/profit for the year on discontinued operations | |||||
| Loss for the year (all attributable to owners of the parent) | |||||
| American depositary share | |||||
| Class A Ordinary shares | |||||
| Total loss for the year (all attributable to owners of the parent) | |||||
| Basic loss per ADS (US Dollars) – continuing operations | |||||
| American depositary share | |||||
| Class A Ordinary shares | |||||
| Diluted loss per ADS (US Dollars) – continuing operations | |||||
| American depositary share | |||||
| Class A Ordinary shares | |||||
| Basic loss per ADS (US Dollars) – group | |||||
| American depositary share | |||||
| Class A Ordinary shares | |||||
| Diluted loss per ADS (US Dollars) – group | |||||
| American depositary share | |||||
| Class A Ordinary shares | |||||
Loading...